Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Pilot clinical trial of time-restricted eating in patients with metabolic syndrome

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Effect of Dairy Matrix on the Postprandial Blood Metabolome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Why do women with eating disorders decline treatment? A qualitative study of barriers to specialized eating disorder treatment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Associations between Postprandial Gut Hormones and Markers of Bone Remodeling

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Narrative Review of Low-Intake Dehydration in Older Adults

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  • Iwona Światkiewicz
  • Celestyna Mila-Kierzenkowska
  • Alina Woźniak
  • Karolina Szewczyk-Golec
  • Jarosław Nuszkiewicz
  • Joanna Wróblewska
  • Paweł Rajewski
  • Simone J.P.M. Eussen
  • Kristine Færch
  • Emily N.C. Manoogian
  • Satchidananda Panda
  • Pam R. Taub
Vis graf over relationer

Metabolic syndrome (MetS) and erratic eating patterns are associated with circadian rhythm disruption which contributes to an increased cardiometabolic risks. Restricting eating period (time-restricted eating, TRE) can restore robust circadian rhythms and improve cardiometabolic health. We describe a protocol of the Time-Restricted Eating on Metabolic and Neuroendocrine homeostasis, Inflammation, and Oxidative Stress (TREMNIOS) pilot clinical trial in Polish adult patients with MetS and eating period of ≥14 h/day. The study aims to test the feasibility of TRE intervention and methodology for evaluating its efficacy for improving metabolic, neuroendocrine, inflammatory, oxidative stress and cardiac biomarkers, and daily rhythms of behavior for such population. Participants will apply 10-h TRE over a 12-week monitored intervention followed by a 12-week self-directed intervention. Changes in eating window, body weight and composition, biomarkers, and rhythms of behavior will be evaluated. Dietary intake, sleep, activity and wellbeing will be monitored with the myCircadianClock application and questionnaires. Adherence to TRE defined as the proportion of days recorded with app during the monitored intervention in which participants satisfied 10-h TRE is the primary outcome. TREMNIOS will also provide an exploratory framework to depict post-TRE changes in cardiometabolic outcomes and behavior rhythms. This protocol extends previous TRE-related protocols by targeting European population with diagnosed MetS and including long-term intervention, validated tools for monitoring dietary intake and ad-herence, and comprehensive range of biomarkers. TREMNIOS trial will lay the groundwork for a large-scale randomized controlled trial to determine TRE efficacy for improving cardiometabolic health in MetS population.

Udgave nummer2
Sider (fra-til)1-18
Antal sider18
StatusUdgivet - feb. 2021

Bibliografisk note

Funding Information:
The study is funded by Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland. This research received no external funding.

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

ID: 68394754